The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus
Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiological agent of Kaposi's sarcoma (KS), the most frequently arising malignancy in individuals with untreated HIV/AIDS. There are several lines of evidence to indicate that Kaposi's sarcoma oncogenesis is associated with loss o...
Saved in:
| Main Authors: | Rebecca C. Robey, Salvinia Mletzko, Frances M. Gotch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Advances in Virology |
| Online Access: | http://dx.doi.org/10.1155/2010/340356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.
by: Rebecca C Robey, et al.
Published: (2009-06-01) -
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation
by: Fengchun Ye, et al.
Published: (2011-01-01) -
Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B
by: Xin‐Yan Fang, et al.
Published: (2025-07-01) -
Association between Kaposi’s sarcoma-associated herpesvirus genotype and clinical types
by: Shohei Yogi, et al.
Published: (2025-04-01) -
Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
by: Ohad Yogev, et al.
Published: (2014-09-01)